A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor

Ibiayi Dagogo‐Jack, Philicia Moonsamy, Justin F. Gainor, Jochen K. Lennerz, Zofia Piotrowska, W. Marston Linehan, Inga T. Lennes, Lecia V. Sequist, Alice T. Shaw, Kelly Goodwin, Sara E. Stevens, Andrew Do, Subba R. Digumarthy, Kristin S. Price, Alona Muzikansky, Aaron N. Hata, Rebecca S. Heist